Zen Brief

A lawsuit over tariffs on Canadian goods, the U.S. ban on DeepSeek and the Tesla-SpaceX merger study all raise questions about the limits of oversight and executive power. AI diagnostics also move toward FDA review, and oddsmakers reassess how they price NFL upsets.

1. 1 Musk's Tesla-SpaceX Merger Plan Tests Regulatory LimitsElon Musk confirmed Tesla and SpaceX are studying a merger, prompting fresh scrutiny from securities regulators and governance experts.
2. 2 Court to Rule on Trump's Tariff AuthorityA new lawsuit says the administration exceeded its authority with fresh tariffs on Canadian goods, challenging presidential trade power.
3. 3 AI Face-Scan Diagnostics Navigates FDA ReviewA single-photo AI system that gauges patient severity is heading to FDA review, raising questions about validation standards.
4. 4 US Bans Chinese DeepSeek AI Over Security RisksThe U.S. government has banned DeepSeek's AI model, a sign of deeper tech decoupling from China with higher stakes for Silicon Valley.
5. 5 Cardinals' upset win exposes NFL betting model flawsArizona's win over Los Angeles is prompting oddsmakers to reexamine how they price NFL upsets in a volatile season.